James West Archives
Block estrogen to treat lung disease
Aug. 17, 2017—Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health.
Marrow cells’ role in pulmonary hypertension explored
Jul. 28, 2016—Cells from the bone marrow participate in the development of pulmonary arterial hypertension (PAH), and they can also protect against it, according to new findings from a team of Vanderbilt University Medical Center investigators.
Hypertension hiatus
Feb. 23, 2016—New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension.
VU team’s cattle research may yield lung disease clues
Apr. 15, 2015—Vanderbilt University researchers have found a genetic mutation that causes pulmonary hypertension in cattle grazed at high altitude, and which leads to a life-threatening condition called brisket disease.
